PP-50 Population pharmacokinetics and dosing optimisation of latamoxef in neonates
Sign Up to like & getrecommendations! Published in 2017 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2017-esdppp.67
Abstract: Background Latamoxef, a new broad-spectrum oxac-ephem antibiotic, was used off-label in neonates. The present study aims to evaluate pharmacokinetics of latamoxef in neonates and establish appropriate dosing regimen. Methods Blood samples were collected from neonates… read more here.
Keywords: latamoxef neonates; optimisation latamoxef; population pharmacokinetics; pharmacokinetics dosing ... See more keywords
PP-49 Population pharmacokinetics and dosing optimisation of cefoperazone in children
Sign Up to like & getrecommendations! Published in 2017 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2017-esdppp.94
Abstract: Background Cefoperazone is used in children with sus-pected or documented Gram-negative serious infections. Currently, its use is off-label partly because of lack of phar-macokinetic studies. Our aim was to evaluate the pop-ulation pharmacokinetics of Cefoperazone… read more here.
Keywords: cefoperazone; cefoperazone children; population pharmacokinetics; pharmacokinetics dosing ... See more keywords